16–18 May 2022
Beactica Therapeutics presents and participates in partnering at BioEquity Europe 2022 in Milan, Italy.
Join our CEO Per Källblad at Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs in Milan. Per will be attending to speak about our latest products in our pipeline, as well as share our mission to develop novel therapeutics against genetically defined cancers, with high unmet medical need.
Per will be networking and meeting with many investors interested in our vision, as well as providing detail about partnering with us on our drug development journey.
Are you attending? Get in touch with Per to hear all about the future plans for Beactica Therapeutics.
Sign up for the Beactica newsletter to receive our latest news and updates